ADD doesn’t call for
A Dangerous Drug
Contact Us Now

For a free, confidential
assessment

Focalin Psychiatric & Allergic Side Effects

Research shows the Attention Deficit Hyperactive Disorder (ADHD) drug dexmethylphenidate hydrochloride—sold under the brand names Focalin and Focalin XR—might cause psychiatric side effects and allergic reaction side effects.

What Is Focalin? When Is It Prescribed?

Focalin is the brand name for the drug dexmethylphenidate hydrochloride made and sold by the Swiss pharmaceutical company Novartis. It is a prescription medication that is used to treat ADHD. The U.S. Food and Drug Administration (FDA) approved Focalin in November 2001 and Focalin XR in May 2005. Focalin comes in the form of oral tablets usually taken twice daily, and Focalin XR is an extended release capsule. Focalin has been a very successful drug for Novartis; in 2010 pharmacies dispensed 2.5 million Focalin XR prescriptions, amounting to $415 million in revenue for Novartis.

Scientists believe that dexmethylphenidate hydrochloride is a “monoamine reuptake inhibitor,” which means it prevents the absorption of released neurotransmitters. Specifically, it belongs to the norepinephrine-dopamine reuptake inhibitor (NDRI) drug class. Both norepinephrine and dopamine regulate stress levels in the human brain, and a shortage of dopamine inhibits cognition. By increasing their presence, Focalin eases ADHD symptoms.

Focalin Psychiatric Side Effects

In November 2011, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research Office of Surveillance and Epidemiology published a review of post-market adverse events in pediatric (aged 0-16 years) Focalin users. It found that of 167 Focalin adverse events reported to the FDA, 19 were for hallucinations, seven for depression, and eight for suicidal ideations and behaviors. One of the three Focalin fatalities occurred when a seven-year-old child hanged himself, though the report did not place the sole cause on Focalin.

In early 2012, an FDA advisory committee recommended that the FDA revise the Focalin label to include a warning about potentially fatal psychiatric side effects. The FDA declined to do so, which is unusual because the agency frequently adopts its advisory committees’ recommendations. It might still do so in the future.

Focalin Angioedema and Anaphylaxis Side Effects

The Office of Surveillance and Epidemiology’s review also classified one of the 167 adverse events as caused by angioedema, which is a rapid, potentially fatal swelling of the skin. A similar possible side effect is anaphylaxis, which is an allergic reaction that can include angioedema as a symptom. In contrast to the Focalin psychiatric side effects, the FDA did incorporate angioedema and anaphylaxis warnings into Focalin’s drug label, most recently revised in May 2012.

RLG’s Lawyers Will Make Things Easier

The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The lawyers of the Rottenstein Law Group believe that obtaining legal satisfaction from those who have harmed you or your child shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Focalin lawsuit on your behalf if necessary.

If you or a loved one took Focalin and believe it caused an injury, contact RLG today.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.

*

  


− three = 4

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.